vs
Side-by-side financial comparison of Gloo Holdings, Inc. (GLOO) and ORTHOPEDIATRICS CORP (KIDS). Click either name above to swap in a different company.
ORTHOPEDIATRICS CORP is the larger business by last-quarter revenue ($61.6M vs $32.6M, roughly 1.9× Gloo Holdings, Inc.). ORTHOPEDIATRICS CORP runs the higher net margin — -16.4% vs -116.9%, a 100.5% gap on every dollar of revenue. ORTHOPEDIATRICS CORP produced more free cash flow last quarter ($9.7M vs $-63.4M).
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
GLOO vs KIDS — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $32.6M | $61.6M |
| Net Profit | $-38.0M | $-10.1M |
| Gross Margin | — | 73.2% |
| Operating Margin | -82.0% | -13.3% |
| Net Margin | -116.9% | -16.4% |
| Revenue YoY | — | 17.0% |
| Net Profit YoY | 12.2% | 37.1% |
| EPS (diluted) | $-6.08 | $-0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $32.6M | $61.6M | ||
| Q3 25 | — | $61.3M | ||
| Q2 25 | — | $61.1M | ||
| Q1 25 | — | $52.4M | ||
| Q4 24 | — | $52.7M | ||
| Q3 24 | — | $54.6M | ||
| Q2 24 | — | $52.8M | ||
| Q1 24 | — | $44.7M |
| Q4 25 | $-38.0M | $-10.1M | ||
| Q3 25 | — | $-11.8M | ||
| Q2 25 | — | $-7.1M | ||
| Q1 25 | — | $-10.7M | ||
| Q4 24 | — | $-16.1M | ||
| Q3 24 | — | $-7.9M | ||
| Q2 24 | — | $-6.0M | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | — | 73.2% | ||
| Q3 25 | — | 73.9% | ||
| Q2 25 | — | 72.1% | ||
| Q1 25 | — | 73.0% | ||
| Q4 24 | — | 67.5% | ||
| Q3 24 | — | 73.4% | ||
| Q2 24 | — | 77.3% | ||
| Q1 24 | — | 72.0% |
| Q4 25 | -82.0% | -13.3% | ||
| Q3 25 | — | -15.4% | ||
| Q2 25 | — | -17.4% | ||
| Q1 25 | — | -21.0% | ||
| Q4 24 | — | -26.7% | ||
| Q3 24 | — | -10.2% | ||
| Q2 24 | — | -10.7% | ||
| Q1 24 | — | -21.8% |
| Q4 25 | -116.9% | -16.4% | ||
| Q3 25 | — | -19.2% | ||
| Q2 25 | — | -11.6% | ||
| Q1 25 | — | -20.3% | ||
| Q4 24 | — | -30.5% | ||
| Q3 24 | — | -14.5% | ||
| Q2 24 | — | -11.4% | ||
| Q1 24 | — | -17.5% |
| Q4 25 | $-6.08 | $-0.43 | ||
| Q3 25 | — | $-0.50 | ||
| Q2 25 | — | $-0.30 | ||
| Q1 25 | — | $-0.46 | ||
| Q4 24 | — | $-0.70 | ||
| Q3 24 | — | $-0.34 | ||
| Q2 24 | — | $-0.26 | ||
| Q1 24 | — | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $15.1M | $60.9M |
| Total DebtLower is stronger | $176.5M | $106.0M |
| Stockholders' EquityBook value | $-444.4M | $346.6M |
| Total Assets | $206.7M | $508.6M |
| Debt / EquityLower = less leverage | — | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $15.1M | $60.9M | ||
| Q3 25 | — | $57.7M | ||
| Q2 25 | — | $70.1M | ||
| Q1 25 | — | $58.8M | ||
| Q4 24 | — | $68.8M | ||
| Q3 24 | — | $76.1M | ||
| Q2 24 | — | $28.9M | ||
| Q1 24 | — | $47.7M |
| Q4 25 | $176.5M | $106.0M | ||
| Q3 25 | — | $105.3M | ||
| Q2 25 | — | $102.7M | ||
| Q1 25 | — | $77.4M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $76.9M | ||
| Q2 24 | — | $11.2M | ||
| Q1 24 | — | $11.3M |
| Q4 25 | $-444.4M | $346.6M | ||
| Q3 25 | — | $349.3M | ||
| Q2 25 | — | $355.5M | ||
| Q1 25 | — | $347.1M | ||
| Q4 24 | — | $354.6M | ||
| Q3 24 | — | $370.9M | ||
| Q2 24 | — | $371.3M | ||
| Q1 24 | — | $370.6M |
| Q4 25 | $206.7M | $508.6M | ||
| Q3 25 | — | $493.5M | ||
| Q2 25 | — | $503.6M | ||
| Q1 25 | — | $470.3M | ||
| Q4 24 | — | $473.2M | ||
| Q3 24 | — | $489.3M | ||
| Q2 24 | — | $430.8M | ||
| Q1 24 | — | $437.2M |
| Q4 25 | — | 0.31× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.03× | ||
| Q1 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.0M | $10.3M |
| Free Cash FlowOCF − Capex | $-63.4M | $9.7M |
| FCF MarginFCF / Revenue | -194.8% | 15.8% |
| Capex IntensityCapex / Revenue | 1.4% | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.0M | $10.3M | ||
| Q3 25 | — | $-581.0K | ||
| Q2 25 | — | $-10.5M | ||
| Q1 25 | — | $-4.2M | ||
| Q4 24 | — | $-4.0M | ||
| Q3 24 | — | $-10.3M | ||
| Q2 24 | — | $-6.1M | ||
| Q1 24 | — | $-6.7M |
| Q4 25 | $-63.4M | $9.7M | ||
| Q3 25 | — | $-3.4M | ||
| Q2 25 | — | $-13.9M | ||
| Q1 25 | — | $-8.4M | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | — | $-11.7M | ||
| Q2 24 | — | $-12.8M | ||
| Q1 24 | — | $-13.2M |
| Q4 25 | -194.8% | 15.8% | ||
| Q3 25 | — | -5.6% | ||
| Q2 25 | — | -22.8% | ||
| Q1 25 | — | -16.0% | ||
| Q4 24 | — | -8.1% | ||
| Q3 24 | — | -21.4% | ||
| Q2 24 | — | -24.2% | ||
| Q1 24 | — | -29.4% |
| Q4 25 | 1.4% | 1.0% | ||
| Q3 25 | — | 4.6% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 8.1% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 12.7% | ||
| Q1 24 | — | 14.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GLOO
| Platform Solutions | $12.7M | 39% |
| Advertising | $11.1M | 34% |
| Marketplace | $3.9M | 12% |
| Midwestern Acquisition | $2.7M | 8% |
| Servant Acquisition | $1.8M | 6% |
KIDS
Segment breakdown not available.
